F. van Valen
Impact in
- Oncology top 5%
- Bone health and treatments
- Cancer-related Molecular Pathways
- Cancer Research top 10%
Papers in
-
- Cell death mechanisms and regulation 4
- Chemical Synthesis and Analysis 4
- Oncology 17
- Bone health and treatments 5
- Co-authors
- Barbara Dockhorn‐Dworniczak (11 shared papers)Klaus‐Michael Debatin (4 shared papers)Simone Fulda (3 shared papers)Éric Meyer (1 shared paper)H. Jürgens (10 shared papers)W. Winkelmann (8 shared papers)Winfried Winkelmann (9 shared papers)Heribert Jürgens (10 shared papers)
- Journals
- Journal of Cancer Research and Clinical Oncology (6 papers)Biochemical and Biophysical Research Communications (4 papers)International Journal of Cancer (3 papers)Oncogene (2 papers)Planta Medica (2 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
F. van Valen
50 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 91
- Oncology 472
- Cancer Research 194
- Pulmonary and Respiratory Medicine 404
- Immunology 244
- Molecular Biology 814
Countries citing papers authored by F. van Valen
This map shows the geographic impact of F. van Valen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. van Valen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. van Valen more than expected).
Fields of papers citing papers by F. van Valen
This network shows the impact of papers produced by F. van Valen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. van Valen. The network helps show where F. van Valen may publish in the future.
Co-authors
The 25 scholars most cited alongside F. van Valen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 344 | |
| 2 | 2001 | 147 | |
| 3 | 2009 | 78 | |
| 4 | 2003 | 75 | |
| 5 | 2001 | 71 | |
| 6 | 2004 | 62 | |
| 7 | 2002 | 60 | |
| 8 | 1994 | 56 | |
| 9 | 1990 | 53 | |
| 10 | 2000 | 52 | |
| 11 | 1992 | 44 | |
| 12 | 2003 | 41 | |
| 13 | 2012 | 39 | |
| 14 | 2005 | 33 | |
| 15 | 1979 | 28 | |
| 16 | 2001 | 27 | |
| 17 | 1993 | 27 | |
| 18 | 1992 | 25 | |
| 19 | 1991 | 25 | |
| 20 | 1994 | 23 |
About F. van Valen
F. van Valen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Neurology and Immunology, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), Neuroblastoma Research and Treatments (7 papers), Bone health and treatments (5 papers), Neuropeptides and Animal Physiology (5 papers), Virus-based gene therapy research (4 papers), Cell death mechanisms and regulation (4 papers), Chemical Synthesis and Analysis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Oncology (472 citations), Cancer Research (194 citations), Pulmonary and Respiratory Medicine (404 citations), Immunology (244 citations) and Molecular Biology (814 citations). F. van Valen has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Barbara Dockhorn‐Dworniczak, Klaus‐Michael Debatin, Simone Fulda, Éric Meyer, H. Jürgens, W. Winkelmann, Winfried Winkelmann, Heribert Jürgens, Christopher Poremba and E. Keck. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Biochemical and Biophysical Research Communications, International Journal of Cancer, Oncogene and Planta Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.